Action signal — 🔍 Research

Surfaced by the 2026-10-16 actions digest.

Action: 🔍 Research (LOW) RSI: 33.5

Why this is in actions

Clinical-stage veto; thesis rated intact-but-priced. Fell more than 6% on October 9 after new Rasonque data (Endpoints, October 9). News pull failed (429, attempt Jul 14); news not pulled for this move. Report listed Nov 4 (provider date). 8-K filed Oct 13, unread.

Trade Summary

Stub — 🔍 Research means more research needed before action.

Sources

• Actions digest: 2026-10-16-actions-daily-digest
• Original row: | RVMD | $177.96 | hold the 200-day ($151.62) | 33.5 | -9.17% | 258.21% | 17.4% | 2026-10-16 | monster-scan (Secular) | 🔍 Research | Clinical-stage veto; thesis rated intact-but-priced. Fell more tha
• Price truth: summaries